MyAverix Finance
US · Healthcare
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT)
Drug Manufacturers - Specialty & Generic
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — FAQ
What is ZYBT's P/E ratio?
The price-to-earnings (P/E) ratio for Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is 18.00 (data as of 2026-05-23).
Does Zhengye Biotechnology Holding Limited Ordinary Shares pay a dividend?
Dividend yield is not available in the current snapshot for Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhengye Biotechnology Holding Limited Ordinary Shares in?
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ZYBT listed on?
ZYBT is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.